Different prognostic indices in 310 patients with tonsillar carcinomas

Head and Neck

Volumn 25, Issue 2, 2003, Pages 123-131

  Hannisdal, Kirsten ^a   Boysen, Morten ^a   Evensen, Jan F ^b  

^a UNIVERSITY OF OSLO   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Carcinomas of the tonsillar region; Prognostic index; Staging; Survival; Validity

Indexed keywords

ADULT; AGE; ARTICLE; CANCER RADIOTHERAPY; CANCER STAGING; FEMALE; GENDER; HEAD AND NECK CANCER; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; RISK FACTOR; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; TONSIL CARCINOMA; VALIDATION PROCESS;

AGE FACTORS; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RADIOTHERAPY DOSAGE; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX; SEX FACTORS; STATISTICS; SURVIVAL ANALYSIS; TIME FACTORS; TONSILLAR NEOPLASMS;

EID: 0037304512     PISSN: 10433074     EISSN: None     Source Type: Journal    
DOI: 10.1002/hed.10175     Document Type: Article

References (25)

1. Hermanek P, Sobin LH, Fleming ID. What do we need beyond TNM? [editorial]. Cancer 1996;77:815-817.
2. Hart AA, Mak-Kregar S, Hilgers FJ, et al. The importance of correct stage grouping in oncology. Results of a nationwide study of oropharyngeal carcinoma in The Netherlands. Cancer 1995;75:2656-2662.
3. Berg H. Die prognostische relevanz des TNM-systems für Oropharynxkarzinome. Tumordiagn u Ther 1992;13: 171-177.
4. Jones GW, Browman G, Goodyear M, Marcellus D, Hodson DI. Comparison of the addition of T and N integer scores with TNM stage groups in head and neck cancer. Head Neck 1993;15:497-503.
5. Snyderman CH, Wagner RL. Superiority of the T and N integer score (TANIS) staging system for squamous cell carcinoma of the oral cavity. Otolaryngol Head Neck Surg 1995;112:691-694.
6. Hall SF, Groome PA, Rothwell D, Dixon PF. Using TNM staging to predict survival in patients with squamous cell carcinoma of head & neck. Head Neck J Sci Spec Head Nec 1999;21:30-38.
7. Carinci F, Pelucchi S, Farina A, Calearo C. A comparison between TNM and TANIS stage grouping for predicting prognosis of oral and oropharyngeal cancer [see comments]. J Oral Maxillofac Surg 1998; 56:832-836; discussion 836-837.
8. Ambrosch P, Kron M, Freudenberg LS. Clinical staging of oropharyngeal carcinoma: a critical evaluation of a new stage grouping proposal [see comments]. Cancer 1998;82: 1613-1620.
9. Groome PA, Schulze K, Boysen M, Hall SF, Mackillop WJ. A comparison of published head and neck stage groupings in carcinomas of the oral cavity. Head Neck 2001;23: 613-624.
10. Lydiatt WM, Shah JP, Hoffman HT, Head and Neck Sites Task Force, American Joint Committee on Cancer. AJCC stage groupings for head and neck cancer: should we look at alternatives? A report of the Head and Neck Sites Task Force. Head Neck 2001;23:607-612.
11. Bjordal K, Kaasa S, Mastekaasa A. Quality of life in patients treated for head and neck cancer: a follow-up study 7 to 11 years after radiotherapy. International J Radiat Oncol Biol Phys 1994;28:847-856.
12. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-481.
13. Peto R, Pike MC, Armitage P, et al. Design and analysis of randomized clinical trials requiring prolonged observation for each patient. II. Analysis and examples. Br J Cancer 1977;35:1-39.
14. Cox RD. Regression models and life-tables. J R Stat Soc 1972;34B:187-220.
15. Bentzen SM, Johansen LV, Overgaard J, Thames HD. Clinical radiobiology of squamous cell carcinoma of the oropharynx. Int J Radiat Oncol Biol Phys 1991;20: 1197-1206.
16. Faye-Lund H. [Prognostic factors in squamous cell carcinomas of the head and neck]. [Review] [Norwegian]. Tidsskrift for Den Norske Laegeforening 1998;118: 2785-2787.
17. Lindelov B, Monberg J, Sand H. Squamous cell carcinoma of the oropharynx. Results of primary radiotherapy. Acta Oncologica 1992;31:341-345.
18. Mantravadi RV, Liebner EJ, Ginde JV. An analysis of factors in the successful management of cancer of tonsillar region. Cancer 1978;41:1054-1058.
19. Lusinchi A, Wibault P, Marandas P, Kunkler I, Eschwege F. Exclusive radiation therapy: the treatment of early tonsillar tumors. Int J Radiat Oncol Biol Phys 1989;17: 273-277.
20. Cooper JS, Farnan NC, Asbell SO, et al. Recursive partitioning analysis of 2105 patients treated in Radiation Therapy Oncology Group studies of head and neck cancer. Cancer 1996;77:1905-1911.
21. al Abdulwahed S, Kudryk W, al Rajhi N, et al. Carcinoma of the tonsil: prognostic factors. J Otolaryngol 1997;26: 296-299.
22. Bataini JP, Asselain B, Jaulerry C, et al. A multivariate primary tumour control analysis in 465 patients treated by radical radiotherapy for cancer of the tonsillar region: clinical and treatment parameters as prognostic factors [see comments]. Radiother Oncol 1989;14:265-277.
23. Thames HD, Bentzen SM. Time factor for tonsillar carcinoma [editorial; comment]. Int J Radiat Oncol Biol Phys 1995;33:755-758.
24. Perez CA, Patel MM, Chao KS, et al. Carcinoma of the tonsillar fossa: prognostic factors and long-term therapy outcome. International J Radiat Oncol Biol Phys 1998;42: 1077-1084.
25. Lewin F, Damber L, Jonsson H, et al. Neoadjuvant chemotherapy with cisplatin and 5-fluorouracil in advanced squamous cell carcinoma of the head and neck: a randomized phase III study. Radiother Oncol 1997;43:23-28.